Chemical industry – Page 100
-
Business
Pfizer to pay $250m for Nexium
AstraZeneca has sold rights to an over the counter version of its heartburn tablets
-
Business
Elan spins off drug discovery
The new company will be called Neotope Biosciences and focus on chronic degenerative diseases
-
Business
DSM to cut 1000 jobs
Netherlands speciality chemical company will reduce its headcount by 1000 over the next 18 months
-
Business
DSM buys into cattle supplements
The company has struck a EUR465 million deal to acquire Tortuga
-
Business
Bapineuzunab dropped
Development for the Alzheimer’s treatment stopped after clinical tests
-
BusinessIrish pharma exports tumble
Seven of the top 10 drugs going off patent between 2011 and 2014 are produced in Ireland
-
Business
Pfizer secures Sandwich buyer
The R&D site in Sandwich, UK, has been bought by a private consortium
-
Business
Monsanto wins $1bn in patent case
Monsanto had claimed that DuPont infringed its patents covering glyphosate pesticide products
-
Business
New cystic fibrosis drug in EU
Ivacaftor works by helping defective proteins function more normally
-
Business
China to investigate polysilicon imports
An ongoing international row over the market for solar panels is spilling over into the supply chain
-
Business
AkzoNobel sells ICI Pakistan
Yunus Brothers will pay $150 million for the recently restructured business
-
Business
New US chemical rules edge nearer
Chemical manufacturers would have to produce safety data for their products
-
Business
Drugs top EU counterfeit imports
In 2011, medicines topped the list of fake products entering the EU
-
Business
UK urged to clean up London air
Think tank says ‘invisible’ pollution is public health problem comparable to obesity and alcohol
-
Business
GSK secures $3.6bn HGS deal
GlaxoSmithKline is set to buy Human Genome Sciences for $3.6 billion
-
BusinessObesity drug approved in US
Qsymia from Vivus joins Belviq in a lucrative part of the pharma industry
-
Business
First HIV drug approved as prevention
Truvada tablets can reduce the risk of infection for an HIV-negative person
-
BusinessThe future of PVC production?
Commercial interest in a semi-continuous approach seems to be on the rise
-
Business
Drug spending to hit $1.2tn in 2016
Growth is expected to bottom out at 3–4% for 2012 and then rise to 5–7% for 2016